Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP
暂无分享,去创建一个
S. Ogawa | M. Kurokawa | K. Izutsu | H. Hirai | S. Chiba | Y. Imai | E. Nitta | Y. Yamaguchi
[1] M. Cleary,et al. Dimerization: a versatile switch for oncogenesis. , 2004, Blood.
[2] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[3] J. Hess,et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. , 2003, Cancer cell.
[4] M. Cleary,et al. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. , 2003, Cancer cell.
[5] Bob Löwenberg,et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. , 2003, Blood.
[6] M. Kurokawa,et al. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP , 2002, Oncogene.
[7] M. Crossley,et al. Evi-1 Transforming and Repressor Activities Are Mediated by CtBP Co-repressor Proteins* , 2001, The Journal of Biological Chemistry.
[8] M. Kurokawa,et al. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. , 2001, Blood.
[9] Shigeru Chiba,et al. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis , 2001, Oncogene.
[10] D. Bonci,et al. Formation of PML/RARα high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RARα-mediated retinoic acid response , 1999, Oncogene.
[11] M. Cleary,et al. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies , 1999, British journal of haematology.
[12] G. Privé,et al. Crystal structure of the BTB domain from PLZF. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Irie,et al. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 , 1998, Nature.
[14] G. Shao,et al. The PR Domain of the Rb-binding Zinc Finger Protein RIZ1 Is a Protein Binding Interface and Is Related to the SET Domain Functioning in Chromatin-mediated Gene Expression* , 1998, The Journal of Biological Chemistry.
[15] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[16] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[17] J. Rowley,et al. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Shao,et al. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[19] Shi Huang. Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF1 , 1994, Cell.
[20] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[21] Y. Yazaki,et al. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. , 1998, Blood.